Healing the Future: How Israeli Innovation is Transforming Wound Care & Dialysis Monitoring
Written by Casey Iaccino, MIBA Director of Innovation and Economic Expansion
In this month’s Spotlight on Innovation, we highlight how Israeli medical technology is transforming healthcare with life-saving advancements in wound care and dialysis monitoring. Two companies, SilverStream Medical and PatenSee, are leading the way, and Michigan is playing a pivotal role in their U.S. expansion.
A Life-Saving Breakthrough from Israel
Imagine suffering from a chronic wound that refuses to heal, or enduring years of dialysis treatments without knowing if a critical issue is developing. For millions of patients worldwide, these are painful, life-threatening realities. But thanks to groundbreaking Israeli medical technology, hope is on the horizon.
Enter SilverStream Medical and PatenSee, two companies redefining what’s possible in advanced wound care and dialysis monitoring—and they’re bringing their life-changing innovations to Michigan.
SilverStream: Healing Wounds, Changing Lives
For patients with diabetic foot ulcers, burns, and pressure sores, traditional treatments often fall short—leading to pain, infections, and even amputations. But SilverStream Medical has developed a revolutionary solution that is changing the game.
With its patented wound-healing technology, SilverStream is clinically proven to accelerate healing, reduce infections, and improve quality of life. Already FDA-approved and used in 25+ countries, SilverStream has treated nearly 500,000 patients—giving people a second chance at mobility, dignity, and a future without chronic pain.
Learn more about SilverStream.
PatenSee: A New Era in Dialysis Monitoring
For patients undergoing hemodialysis, vascular access failure is one of the most dangerous risks—yet, until now, early warning systems have been almost nonexistent. PatenSee’s contactless imaging technology changes that.
By enabling non-invasive, real-time monitoring, PatenSee helps detect potential complications before they become life-threatening. Through its partnership with Henry Ford Health, PatenSee is piloting this technology in Michigan, bringing hope to thousands of dialysis patients who deserve better, safer care.
“PatenSee’s goal is to enhance the quality of patient monitoring and reduce complications, while alleviating the burden on clinical staff.” – Shai Policker, Interim CEO of PatenSee
Learn more about PatenSee.
Why This Matters for Michigan (and the World)
Both SilverStream and PatenSee are examples of how Israeli innovation is tackling some of the toughest medical challenges—and Michigan is playing a critical role in their U.S. expansion. Thanks to strategic introductions from the Michigan Israel Business Accelerator (MIBA), these companies are forming key partnerships, securing funding, and establishing a presence in the state’s growing health tech ecosystem.
Better healing. Earlier detection. Fewer hospitalizations. More lives saved.
That’s what these game-changing technologies represent—not just in Michigan, but for patients everywhere.
